Project Details
| Status | Active |
|---|---|
| Effective start/end date | 24/04/2023 → 23/04/2026 |
Collaborative partners
- King's College London (lead)
- UBC University of British Columbia
Funding
- MRC Medical Research Council: £593,513.70
Pharmacological inhibition or genetic deletion of a neurotoxin found abundantly at sites of spinal cord injury will neuroprotect and improve outcome
- Bradbury, Elizabeth (Primary Investigator)
- Ahmed, Aminul (Co-Investigator)
- Ivetic, Alex (Co-Investigator)
Project: Research